Biomimetic oxidation of chromium(III): Does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)?

Angewandte Chemie - International Edition

Volumn 43, Issue 34, 2004, Pages 4504-4507

  Mulyani, Irma ^a   Levina, Aviva ^a   Lay, Peter A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bioinorganic chemistry; Biological activity; Chromium; Enzyme inhibitors; Oxidation

Indexed keywords

CARCINOGENS; ENZYMES; INSULIN; OXIDATION; PHASE SEPARATION;

BIOMIMETIC OXIDATION; OXIDANTS;

CHROMIUM;

ANTIDIABETIC AGENT; CARCINOGEN; CELL RECEPTOR; CHROMIUM; FAT; GLUCOSE; INSULIN; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; COMPLEX FORMATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; OXIDATION;

BIOMIMETICS; CARCINOGENS, ENVIRONMENTAL; CHROMIUM; CHROMIUM COMPOUNDS; HYPOGLYCEMIC AGENTS; OXIDANTS; OXIDATION-REDUCTION;

EID: 4544259176     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200460113     Document Type: Article

References (43)

1. R. A. Anderson, J. Am. Coll Nutr. 1998, 17, 548-555.
2. D. M. Stearns, BioFactors 2000, 11, 149-162.
3. A. Levina, R. Codd, C. T. Dillon, P. A. Lay, Prog. Inorg. Chem. 2003, 51, 145-250, and references therein.
4. a) C. M. Davis, J. B. Vincent, Biochemistry 1997, 36, 4382-4385;
5. b) L. Jacquamet, Y. Sun, J. Hatfield, W. Gu, S. P. Cramer, M. W. Crowder, G. A. Lorigan, J. B. Vincent, J.-M. Latour, J. Am. Chem. Soc. 2003, 725, 774-780;
6. c) J. B. Vincent, J. Trace Elem. Exp. Med. 2003, 16, 227-236.
7. E. Gaggelli, F. Berti, N. D'Amelio, N. Gaggelli, G. Valensin, L. Bovalini, A. Paffetti, L. Trabalzini, Environ. Health Perspect. 2002, 770, 733-738.
8. A. S. Antsyshkina, M. A. Porai-Koshits, I. V. Arkhangel'skii, I. N. Diallo, Zh. Neorg. Khim. 1987, 32, 2928-2932; Engl. transl.: A. S. Antsyshkina, M. A. Porai-Koshits, I. V. Arkhangel'skii, I. N. Diallo, Russ. J. Inorg. Chem. 1987, 32, 1700-1703.
9. A. S. Antsyshkina, M. A. Porai-Koshits, I. V. Arkhangel'skii, I. N. Diallo, Zh. Neorg. Khim. 1987, 32, 2928-2932; Engl. transl.: A. S. Antsyshkina, M. A. Porai-Koshits, I. V. Arkhangel'skii, I. N. Diallo, Russ. J. Inorg. Chem. 1987, 32, 1700-1703.
10. The ability of nM concentrations of 1 to enhance the tyrosine kinase activity of β subunits of insulin receptors has been reported (C. M. Davis, A. C. Royer, J. B. Vincent, Inorg. Chem. 1997, 36, 5316-5320), but our attempts to reproduce these results were not successful.
11. a) Y. J. Sun, K. Mallya, J. Ramirez, J. B. Vincent, J. Biol. Inorg. Chem. 1999, 4, 838-845;
12. b) J. B. Vincent, C. M. Davis (University of Alabama), US Patent 6197816, 2001 [Chem. Abstr. 2001, 134, 207223];
13. c) Y. J. Sun, B. J. Clodfelder, A. A. Shute, T. Irvin, J. B. Vincent, J. Biol Inorg. Chem. 2002, 7, 852-862.
14. a) D. M. Stearns, W. H. Armstrong, Inorg. Chem. 1992, 31, 5178-5184;
15. b) D. M. Stearns, S. M. Silveira, K. K. Wolf, A. M. Luke, Mutat. Res. 2002, 575, 135-142;
16. c) D. D. D. Hepburn, J. Xiao, S. Bindom, J. B. Vincent, J. O'Donnell, Proc. Natl. Acad. Sci. USA 2003, 700, 3766-3771.
17. F. L. Petrilli, S. DeFlora, Mutat. Res. 1978, 58, 167-173.
18. a) R. Codd, C. T. Dillon, A. Levina, P. A. Lay, Coord. Chem. Rev. 2001, 216-217, 533-577;
19. b) A. Levina, P. A. Lay, Coord. Chem. Rev. 2004, in press.
20. a) P. J. Stankiewicz, A. S. Tracey, D. C. Crans in Metal Ions in Biological Systems, Vol. 31 (Eds.: H. Sigel, A. Sigel), Marcel Dekker, New York, 1995, pp. 287-324;
21. b) M. Zhang, M. Zhou, R. L. Van Etten, C. V. Stauffacher, Biochemistry 1997, 36, 15-23.
22. B. Halliwell in Active Oxygen in Biochemistry (Eds.: J. S. Valentine, C. S. Foote, A. Greenberg, J. F. Liebman), Blackie Academic and Professional, London, 1995, pp. 313-335.
23. a) G. W. Haupt, Natl. Bur. Stand. Circ. 1952, 48, 414-423;
24. b) J. E. T. Andersen, Anal. Chim. Acta 1998, 361, 125-131.
25. a) S. C. Pal, M. T. H. Tarafder, Indian J. Chem. Sect. A 1996,35, 960-963;
26. b) R. Rajan, B. U. Nair, T. Ramasami, Inorg. React. Mech. 2000, 7, 247-255.
27. P. A. Lay, A. Levina in Comprehensive Coordination Chemistry II, Vol. 4 (Eds.: J. A. McCleverty, T. J. Meyer), Elsevier, Oxford, UK, 2004, pp. 313-413.
28. a) Standard Methods for the Examination of Water and Waste-water, 16th ed., American Public Health Association, Washington, DC, 1985, Sect. 312B, pp. 201-204;
29. b) A. Levina, A. M. Bailey, G. Champion, P. A. Lay, J. Am. Chem. Soc. 2000, 122, 6208-6216.
30. J. P. Klinman, J. Biol. Inorg. Chem. 2001, 6, 1-13, and references therein.
31. C. Vorbach, R. Harrison, M. R. Capecchi, Trends Immunol. 2003, 24, 512-517, and references therein.
32. V complexes reactions biomolecules in vitro.[3.11a]
33. a) Z.-Y. Zhang, J. C. Clemens, H. L. Schubert, J. A. Stuckey, M. W. F. Fischer, D. M. Hume, M. A. Saper, J. E. Dixon, J. Biol. Chem. 1992, 267, 23759-23766;
34. b) Z.-Y. Zhang, Y. Wang, L. Wu, E. B. Fauman, J. A. Stuckey, H. L. Schubert, M. A. Saper, J. E. Dixon, Biochemistry 1994, 33, 15266-15270.
35. IV and organic radical species, which are likely to contribute to PTP inhibition (A. Kortenkamp, M. Casadevall, S. P. Faux, A. Jenner, R. O. J. Shayer, N. Woodbridge, P. O'Brien, Arch. Biochem. Biophys. 1996, 329, 199-207).
36. III ions.[3] No significant effects of 1 or chromodulin on human PTPs were found, contrary to the earlier reports.[4,7]
37. A. Levina, P. A. Lay, Inorg. Chem. 2004, 43, 324-335.
38. C. T. Dillon, P. A. Lay, A. M. Bonin, M. Cholewa, G. J. F. Legge, Chem. Res. Toxicol. 2000, 13, 742-748.
39. a) E. J. Yurkow, G. Kim, Mol. Pharmacol. 1995, 47, 686-695;
40. b) Y. Qian, B. Jiang, D. C. Flynn, S. S. Leonard, S. W. Wang, Z. Zhang, J. P. Ye, F. Chen, L. Y. Wang, X. L. Shi, Mol. Cell. Biochem. 2001, 222, 199-204.
41. a) E. Kim, K. J. Na, Toxicol. Appl. Pharmacol. 1991, 110, 251-258;
42. b) Y. Goto, K. Kida, Jpn. J. Pharmacol. 1995, 67, 365-368.
43. S. A. Kareus, C. Kelley, H. S. Walton, P. R. Sinclair, J. Hazard. Mater. B 2001, 84, 163-174.